Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial

BACKGROUND: The androgen receptor (AR) is discussed as a prognostic and/or predictive marker in breast cancer patients. METHODS: AR mRNA expression was analysed by RT-qPCR in breast cancer patients treated in the neoadjuvant TECHNO (n  =  118, HER2-positive) and PREPARE trial (n  =  321, HER2-positi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Witzel, Isabell, Loibl, Sibylle, Wirtz, Ralph, Fasching, Peter A., Denkert, Carsten, Weber, Karsten, Lück, Hans-Joachim, Huober, Jens, Karn, Thomas, Mackelenbergh, Marion von, Marmé, Frederik, Schem, Christian, Stickeler, Elmar, Untch, Michael, Müller, Volkmar
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964685/
https://ncbi.nlm.nih.gov/pubmed/31728025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0630-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars